Overview

Relapsed or Refractory Primary Diffuse Large B-cell Lymphoma (DLBCL) of the Central Nervous System (CNS)

Status:
Not yet recruiting
Trial end date:
2024-02-29
Target enrollment:
Participant gender:
Summary
Relapsed or refractory primary DLBCL of the CNS
Phase:
Phase 2
Details
Lead Sponsor:
Seoul National University Hospital
Collaborator:
Seoul National University Bundang Hospital
Treatments:
Pemetrexed